LILRB4 inhibited T cell proliferation and improved the infiltration of AML cells into organs both in vitro and in vivo, and these effects were reversed by knockout of SHP-2 in human AML cell lines. The gene discussed is PTPN11; the disease is acute myeloid leukemia.